Junaid Bajwa - CNS Summit Host
Chief Medical Scientist
Microsoft

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.
Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.
Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

Dr. Bajwa joined Merck/ MSD 3 years ago as the Executive Director for Healthcare Services for MSD UK, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across MSD and external partnerships across the health care ecosystem. Examples of his team’s work in the past 3 years include establishing VelocityHealth in partnership with Telefonica, winning the NHS Oncology Vanguard project to support Early Identification of Cancer, and securing a novel contract incorporating a pill plus service contract for Hepatitis C. In addition, Dr. Bajwa led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet) which the Health Service Journal recently recognized as the “2018 Best Pharmaceutical Partnership with the NHS”.

Previously, Dr. Bajwa has worked in primary care as a physician and in the payer, provider and regulatory markets within the UK where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM.

Dr. Bajwa received his MBA at the Imperial College Business School in London and studied health strategy and quality improvement at Harvard University (Kennedy School of Public Policy Analysis and Chan School of Public Health) and the Institute of Healthcare Improvement in Boston. He now spearheads MSD’s work in Global Strategic Alliances for the DigitalCentre of Excellence.